Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Acute gastroenteritis (AGE) is an extremely common paediatric condition, which results in significant morbidity in children and is a financial burden to the society. Objective: The purpose of this overview is to critically evaluate the evidence currently available in the Cochrane Database of Systematic Reviews (CDSR) regarding the efficacy and safety of commonly considered treatment options in children with AGE. Methods: All Cochrane reviews evaluating the following treatments in children with AGE were eligible for inclusion: oral rehydration therapy, anti‐emetics and probiotics. We excluded those focusing on the treatment of antibiotic associated or nosocomial diarrhoea, persistent (chronic) diarrhoea and the prevention of gastroenteritis. We focused on the following outcomes that were selected a priori as clinically important: rate of admission to the hospital; length of stay in hospital; rate of return visits; administration of intravenous (IV) therapy owing to failure of oral rehydration therapy; adverse events and dysnatremia. Main results: Children who received oral rehydration therapy had a shorter length of stay in hospital compared with children who received IV therapy [mean difference, MD = −1.20 days (−2.38, −0.02)]; however, the result was no longer significant when an outlying study was removed. Children who received IV therapy were at increased risk of developing phlebitis [risk difference, RD= − 0.02 (−0.04, −0.01)], while paralytic ileus was more common in children receiving ORT [RD = 0.03 (confidence interval, CI 0.01–0.05)]. Children who received oral ondansetron had lower hospital admission rates to the emergency department (ED) and lower rates of IV rehydration during their ED stay compared with children receiving placebo [risk ration, RR = 0.40 (CI 0.19–0.83) and RR = 0.41 (CI 0.29–0.59), respectively]. Children receiving IV ondansetron had lower hospital admission rates to the ED than patients receiving placebo [RR = 0.21 (0.05, 0.93)]. Probiotic use amongst children hospitalized following AGE reduced the mean duration of hospitalization by 1.12 days (CI −1.16, −0.38). Conclusions: Given that oral rehydration is less invasive than IV rehydration with no evidence of important clinical differences, it is the first choice for rehydration in children with AGE and mild‐to‐moderate dehydration. As the vast majority of children with AGE do not require IV rehydration, oral ondansetron administration to children with significant vomiting should be performed to reduce the use of IV rehydration and the need for hospital admission. In children deemed too unwell to receive oral rehydration therapy, IV ondansetron administration is an option, as its use is associated with lower hospital admission rates. Although probiotics appear to be an effective option for the treatment of AGE amongst hospitalized children, outpatient data is lacking and more studies are urgently needed to determine the optimal organism, dosing and duration of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, L., Johnson, H. L., Cousens, S., Perin, J., Scott, S., Lawn, J. E., Rudan, I., Campbell, H., Cibulskis, R., Li, M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60560-1 · Cited by 3,934
Probiotics for treating acute infectious diarrhoea
Allen, S. J., Martinez, E. G., Gregorio, G. V., & Dans, L. F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048.pub3 · Cited by 628
De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284
Developing a database of published reports of randomised clinical trials in pain research 1
Jadad, A. R., Carroll, D., Moore, A., & McQuay, H. (1996) · Pain · doi:10.1016/0304-3959(96)03033-3 · Cited by 271
Vahabnezhad, E., Mochon, A. B., Wozniak, L. J., & Ziring, D. A. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318279abf0 · Cited by 156
Lactobacillemia in three patients with AIDS
Horwitch, C. A., Furseth, H. A., Larson, A. M., Jones, T. L., Olliffe, J. F., & Spach, D. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1460 · Cited by 78
Salari (2012) · doi:10.2174/187152812798889394 · Cited by 78
Cited by
Prescribed drugs containing nitrogen heterocycles: an overview
Heravi, M. M., & Zadsirjan, V. (2020) · RSC Advances · doi:10.1039/d0ra09198g · Cited by 1,194
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix669 · Cited by 627
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix959 · Cited by 532
Traveler’s Diarrhea: A Clinical Review
Steffen, R., Hill, D. R., & DuPont, H. L. (2015) · JAMA · doi:10.1001/jama.2014.17006 · Cited by 349
Mokomane, M., Kasvosve, I., Melo, E. D., Pernica, J. M., & Goldfarb, D. M. (2018) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117744429 · Cited by 262
Metadata
- Authors
- Freedman, S. B., Ali, S., Oleszczuk, M., Gouin, S., & Hartling, L.
- Venue
- Evidence-Based Child Health: A Cochrane Review Journal
- Publisher
- Wiley
- Published
- 2013-07
- Volume
- 8
- Issue
- 4
- Pages
- 1123-1137
- ISSN
- 1557-6272 (ISSN-L)
- OpenAlex
- W2154720817
- Cited by
- 107
- References
- 7
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.